Experts Forecast 2024, Part 3: Precision Medicine for Cancer Treatment
In part 3 of our 2024 Experts Forecast, AACR President-Elect Patricia M. LoRusso, DO, PhD (hc), FAACR, shares thoughts...
In part 3 of our 2024 Experts Forecast, AACR President-Elect Patricia M. LoRusso, DO, PhD (hc), FAACR, shares thoughts...
The year 2022 will be remembered as the time when the emergency phase of the COVID-19 pandemic began to...
2020 was filled with unexpected challenges for cancer research and patient care. As many of us shifted our lives...
The unrestrained cellular proliferation that characterizes cancer largely arises due to genetic mutations, which can impede the regulatory mechanisms that control when and how often a cell divides. Genetic mutations may also...
Head and neck cancers encompass a large group of malignancies that originate in the nasal cavity, sinuses, lips, mouth,...
Around 400 BC, the Greek physician Hippocrates is believed to have first described tumors as “cancer,” using the words...
Rare cancers, when taken all together, make up an estimated 20 to 25 percent of all cancers diagnosed. With...
The spectacular sight of the AACR Annual Meeting 2019 Opening Ceremony, held Sunday, March 31, at the Georgia World...
In 2018, we witnessed significant momentum in several hot areas of cancer research, including immunotherapy and precision medicine. Researchers...
Cancer treatments have been, and continue to be in most cases, based on the organ site where the tumor...